(Q62035312)

English

Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to- Severe Atopic Dermatitis (English)

0 references

0 references

0 references

United States of America

0 references

main subject

Duchenne muscular dystrophy

0 references